麻豆原创

Published on 麻豆原创 Research Reports庐 Inc. ()

麻豆原创 > Global Genetic Carrier Screening Service 麻豆原创 Research Report 2024

Global Genetic Carrier Screening Service 麻豆原创 Research Report 2024

Publication ID: 
PB507246284
Publication Date: 
July 11, 2024
Pages: 
85
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

The global Genetic Carrier Screening Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Genetic Carrier Screening Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Genetic Carrier Screening Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Genetic Carrier Screening Service in Pregnant Woman is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Genetic Carrier Screening Service include Clinical Labs, Eurofins Scientific, Fulgent Genetics, Gene by Gene, Illumina, Invitae, MedGenome Labs, My Baby Company and Myriad Genetics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Genetic Carrier Screening Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Carrier Screening Service.

Report Scope

The Genetic Carrier Screening Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genetic Carrier Screening Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genetic Carrier Screening Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

麻豆原创 Segmentation

By Company

Clinical Labs

Eurofins Scientific

Fulgent Genetics

Gene by Gene

Illumina

Invitae

MedGenome Labs

My Baby Company

Myriad Genetics

Natera

NxGen MDx, LLC

OPKO Health

Thermo Fisher Scientific

Sonic Genetics

Segment by Type

Expanded Carrier Screening Service

Targeted Disease Carrier Screening Service

Segment by Application

Pregnant Woman

Couple

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Genetic Carrier Screening Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Report Overview

1.1 Study Scope

1.2 麻豆原创 Analysis by Type

1.2.1 Global Genetic Carrier Screening Service 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Expanded Carrier Screening Service

1.2.3 Targeted Disease Carrier Screening Service

1.3 麻豆原创 by Application

1.3.1 Global Genetic Carrier Screening Service 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Pregnant Woman

1.3.3 Couple

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Genetic Carrier Screening Service 麻豆原创 Perspective (2019-2030)

2.2 Genetic Carrier Screening Service Growth Trends by Region

2.2.1 Global Genetic Carrier Screening Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030

2.2.2 Genetic Carrier Screening Service Historic 麻豆原创 Size by Region (2019-2024)

2.2.3 Genetic Carrier Screening Service Forecasted 麻豆原创 Size by Region (2025-2030)

2.3 Genetic Carrier Screening Service 麻豆原创 Dynamics

2.3.1 Genetic Carrier Screening Service Industry Trends

2.3.2 Genetic Carrier Screening Service 麻豆原创 Drivers

2.3.3 Genetic Carrier Screening Service 麻豆原创 Challenges

2.3.4 Genetic Carrier Screening Service 麻豆原创 Restraints

3 Competition Landscape by Key Players

3.1 Global Top Genetic Carrier Screening Service Players by Revenue

3.1.1 Global Top Genetic Carrier Screening Service Players by Revenue (2019-2024)

3.1.2 Global Genetic Carrier Screening Service Revenue 麻豆原创 Share by Players (2019-2024)

3.2 Global Genetic Carrier Screening Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Genetic Carrier Screening Service Revenue

3.4 Global Genetic Carrier Screening Service 麻豆原创 Concentration Ratio

3.4.1 Global Genetic Carrier Screening Service 麻豆原创 Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Genetic Carrier Screening Service Revenue in 2023

3.5 Genetic Carrier Screening Service Key Players Head office and Area Served

3.6 Key Players Genetic Carrier Screening Service Product Solution and Service

3.7 Date of Enter into Genetic Carrier Screening Service 麻豆原创

3.8 Mergers & Acquisitions, Expansion Plans

4 Genetic Carrier Screening Service Breakdown Data by Type

4.1 Global Genetic Carrier Screening Service Historic 麻豆原创 Size by Type (2019-2024)

4.2 Global Genetic Carrier Screening Service Forecasted 麻豆原创 Size by Type (2025-2030)

5 Genetic Carrier Screening Service Breakdown Data by Application

5.1 Global Genetic Carrier Screening Service Historic 麻豆原创 Size by Application (2019-2024)

5.2 Global Genetic Carrier Screening Service Forecasted 麻豆原创 Size by Application (2025-2030)

6 North America

6.1 North America Genetic Carrier Screening Service 麻豆原创 Size (2019-2030)

6.2 North America Genetic Carrier Screening Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Genetic Carrier Screening Service 麻豆原创 Size by Country (2019-2024)

6.4 North America Genetic Carrier Screening Service 麻豆原创 Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Genetic Carrier Screening Service 麻豆原创 Size (2019-2030)

7.2 Europe Genetic Carrier Screening Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Genetic Carrier Screening Service 麻豆原创 Size by Country (2019-2024)

7.4 Europe Genetic Carrier Screening Service 麻豆原创 Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Genetic Carrier Screening Service 麻豆原创 Size (2019-2030)

8.2 Asia-Pacific Genetic Carrier Screening Service 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Genetic Carrier Screening Service 麻豆原创 Size by Region (2019-2024)

8.4 Asia-Pacific Genetic Carrier Screening Service 麻豆原创 Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Genetic Carrier Screening Service 麻豆原创 Size (2019-2030)

9.2 Latin America Genetic Carrier Screening Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Genetic Carrier Screening Service 麻豆原创 Size by Country (2019-2024)

9.4 Latin America Genetic Carrier Screening Service 麻豆原创 Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Genetic Carrier Screening Service 麻豆原创 Size (2019-2030)

10.2 Middle East & Africa Genetic Carrier Screening Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Genetic Carrier Screening Service 麻豆原创 Size by Country (2019-2024)

10.4 Middle East & Africa Genetic Carrier Screening Service 麻豆原创 Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Clinical Labs

11.1.1 Clinical Labs Company Detail

11.1.2 Clinical Labs Business Overview

11.1.3 Clinical Labs Genetic Carrier Screening Service Introduction

11.1.4 Clinical Labs Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.1.5 Clinical Labs Recent Development

11.2 Eurofins Scientific

11.2.1 Eurofins Scientific Company Detail

11.2.2 Eurofins Scientific Business Overview

11.2.3 Eurofins Scientific Genetic Carrier Screening Service Introduction

11.2.4 Eurofins Scientific Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.2.5 Eurofins Scientific Recent Development

11.3 Fulgent Genetics

11.3.1 Fulgent Genetics Company Detail

11.3.2 Fulgent Genetics Business Overview

11.3.3 Fulgent Genetics Genetic Carrier Screening Service Introduction

11.3.4 Fulgent Genetics Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.3.5 Fulgent Genetics Recent Development

11.4 Gene by Gene

11.4.1 Gene by Gene Company Detail

11.4.2 Gene by Gene Business Overview

11.4.3 Gene by Gene Genetic Carrier Screening Service Introduction

11.4.4 Gene by Gene Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.4.5 Gene by Gene Recent Development

11.5 Illumina

11.5.1 Illumina Company Detail

11.5.2 Illumina Business Overview

11.5.3 Illumina Genetic Carrier Screening Service Introduction

11.5.4 Illumina Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.5.5 Illumina Recent Development

11.6 Invitae

11.6.1 Invitae Company Detail

11.6.2 Invitae Business Overview

11.6.3 Invitae Genetic Carrier Screening Service Introduction

11.6.4 Invitae Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.6.5 Invitae Recent Development

11.7 MedGenome Labs

11.7.1 MedGenome Labs Company Detail

11.7.2 MedGenome Labs Business Overview

11.7.3 MedGenome Labs Genetic Carrier Screening Service Introduction

11.7.4 MedGenome Labs Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.7.5 MedGenome Labs Recent Development

11.8 My Baby Company

11.8.1 My Baby Company Company Detail

11.8.2 My Baby Company Business Overview

11.8.3 My Baby Company Genetic Carrier Screening Service Introduction

11.8.4 My Baby Company Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.8.5 My Baby Company Recent Development

11.9 Myriad Genetics

11.9.1 Myriad Genetics Company Detail

11.9.2 Myriad Genetics Business Overview

11.9.3 Myriad Genetics Genetic Carrier Screening Service Introduction

11.9.4 Myriad Genetics Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.9.5 Myriad Genetics Recent Development

11.10 Natera

11.10.1 Natera Company Detail

11.10.2 Natera Business Overview

11.10.3 Natera Genetic Carrier Screening Service Introduction

11.10.4 Natera Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.10.5 Natera Recent Development

11.11 NxGen MDx, LLC

11.11.1 NxGen MDx, LLC Company Detail

11.11.2 NxGen MDx, LLC Business Overview

11.11.3 NxGen MDx, LLC Genetic Carrier Screening Service Introduction

11.11.4 NxGen MDx, LLC Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.11.5 NxGen MDx, LLC Recent Development

11.12 OPKO Health

11.12.1 OPKO Health Company Detail

11.12.2 OPKO Health Business Overview

11.12.3 OPKO Health Genetic Carrier Screening Service Introduction

11.12.4 OPKO Health Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.12.5 OPKO Health Recent Development

11.13 Thermo Fisher Scientific

11.13.1 Thermo Fisher Scientific Company Detail

11.13.2 Thermo Fisher Scientific Business Overview

11.13.3 Thermo Fisher Scientific Genetic Carrier Screening Service Introduction

11.13.4 Thermo Fisher Scientific Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.13.5 Thermo Fisher Scientific Recent Development

11.14 Sonic Genetics

11.14.1 Sonic Genetics Company Detail

11.14.2 Sonic Genetics Business Overview

11.14.3 Sonic Genetics Genetic Carrier Screening Service Introduction

11.14.4 Sonic Genetics Revenue in Genetic Carrier Screening Service Business (2019-2024)

11.14.5 Sonic Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

Companies Mentioned: 

Clinical Labs

Eurofins Scientific

Fulgent Genetics

Gene by Gene

Illumina

Invitae

MedGenome Labs

My Baby Company

Myriad Genetics

Natera

NxGen MDx, LLC

OPKO Health

Thermo Fisher Scientific

Sonic Genetics

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-genetic-carrier-screening-service-market-research-report-2024

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare